エディションの選択
国
重点項目
病状
組織の種類
ステークホルダー
品質
First Edition BOGP (0)
Advocacy (policy advocacy, lobbying)
Musculoskeletal/Multiple Sclerosis (MS) (1)
Pharmaceutical Company (9)
Pharmaceutical companies or industry (incl. Medical device and biotech companies)
Representativeness of stakeholders
Clinical study phase II